Key result
Review proposes new structural classification of KCNJ2 mutations to guide personalized Andersen-Tawil syndrome treatment.
Why the study?
The arrhythmogenic mechanisms underlying Andersen-Tawil syndrome are poorly understood, hindering differentiation from overlapping channelopathies and development of individualized therapies.
This review provides a mechanistic understanding of Andersen-Tawil syndrome and proposes a new structural and functional classification of KCNJ2 loss-of-function mutations to guide personalized treatment.
Answers are grounded in this paper and cite their sources.
May support individualized management in Andersen-Tawil syndrome; leaves open prospective validation of the proposed classification.
Andersen-Tawil syndrome (ATS) is a rare inheritable disease associated with loss-of-function mutations in KCNJ2, the gene coding the strong inward rectifier potassium channel Kir2.1, which forms an essential membrane protein controlling cardiac excitability. ATS is usually marked by a triad of periodic paralysis, life-threatening cardiac arrhythmias and dysmorphic features, but its expression is variable and not all patients with a phenotype linked to ATS have a known genetic alteration. The mechanisms underlying this arrhythmogenic syndrome are poorly understood. Knowing such mechanisms would be essential to distinguish ATS from other channelopathies with overlapping phenotypes and to develop individualized therapies. For example, the recently suggested role of Kir2.1 as a countercurrent to sarcoplasmic calcium reuptake might explain the arrhythmogenic mechanisms of ATS and its overlap with catecholaminergic polymorphic ventricular tachycardia. Here we summarize current knowledge on the mechanisms of arrhythmias leading to sudden cardiac death in ATS. We first provide an overview of the syndrome and its pathophysiology, from the patient's bedside to the protein and discuss the role of essential regulators and interactors that could play a role in cases of ATS. The review highlights novel ideas related to some post-translational channel interactions with partner proteins that might help define the molecular bases of the arrhythmia phenotype. We then propose a new all-embracing classification of the currently known ATS loss-of-function mutations according to their position in the Kir2.1 channel structure and their functional implications. We also discuss specific ATS pathogenic variants, their clinical manifestations, and treatment stratification. The goal is to provide a deeper mechanistic understanding of the syndrome toward the development of novel targets and personalized treatment strategies.
No takes yet. Share an insight, caveat, or question.
Moreno-Manuel et al. (2022) conducted a review in Andersen-Tawil syndrome. A review of Andersen-Tawil syndrome proposes a new classification of KCNJ2 loss-of-function mutations based on their position in the Kir2.1 channel structure to guide personalized treatment strategies.
Synapse has enriched 10 related papers. Consider them for comparative context: